Volterra series in pharmacokinetics and pharmacodynamics
- PMID: 14977164
- DOI: 10.1023/b:jopa.0000008158.30235.59
Volterra series in pharmacokinetics and pharmacodynamics
Abstract
Nonparametric black-box modeling has a long successful history of applications in pharmacokinetics (PK) (notably in deconvolution), but is rarely used in pharmacodynamics (PD). The main reason is associated with the fact that PK systems are often linear in respect to drug inputs, while the reverse is true for many PK/PD systems. In the PK/PD field existing non-parametric methods can deal with linear systems, but they cannot describe non-linear systems. Our purpose is to describe a novel implementation of a general nonparametric model which can represent non-linear systems, and in particular non-linear PK/PD systems, The model is based on a Volterra series, which is an integral series expansion of the response of a system in terms of its kernels and the inputs to the system. In PK we are familiar with the first term of the Volterra series, the convolution of the first kernel of the system (the so-called PK disposition function) with drug input rates. The main advantages of higher order Volterra representations is that they are general representations and can be used to describe and predict the response of an arbitrary (PK/ PD) system without any prior knowledge on the structure of the system. The main problem of the representation is that in a non-parametric representation of the kernels the number of parameters to be estimated grows geometrically with the order of the kernel. We developed a method to estimate the kernels in a Volterra-series which overcomes this problem. The method (i) is fully non-parametric (the kernels are represented using multivariate splines), (ii) is maximum-likelihood based, (iii) is adaptive (the order of the series and the dimensionality of each kernel is selected by the method), and (iv) allows for non-equispaced observations (thus allowing a reduction of the number of parameters in the representation, and the analysis of, e.g., PK/PD observations). The method is based on an adaptation of Friedmans's Multivariate Adaptive Regression Spline method. Examples demonstrate the possible application of the approach to the analysis of different PK/PD systems.
Similar articles
-
A unifying view of wiener and volterra theory and polynomial kernel regression.Neural Comput. 2006 Dec;18(12):3097-118. doi: 10.1162/neco.2006.18.12.3097. Neural Comput. 2006. PMID: 17052160
-
Using spline-enhanced ordinary differential equations for PK/PD model development.J Pharmacokinet Pharmacodyn. 2008 Oct;35(5):553-71. doi: 10.1007/s10928-008-9101-9. Epub 2008 Nov 7. J Pharmacokinet Pharmacodyn. 2008. PMID: 18989761
-
Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models.Clin Pharmacol Ther. 1986 Jul;40(1):86-93. doi: 10.1038/clpt.1986.143. Clin Pharmacol Ther. 1986. PMID: 3720181
-
Nonparametric Methods in Population Pharmacokinetics.J Clin Pharmacol. 2022 Feb;62(2):142-157. doi: 10.1002/jcph.1650. Epub 2020 Oct 26. J Clin Pharmacol. 2022. PMID: 33103785 Review.
-
Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.Int J Clin Pharmacol Ther. 1997 Oct;35(10):401-13. Int J Clin Pharmacol Ther. 1997. PMID: 9352388 Review.
Cited by
-
Pharmacokinetic-pharmacodynamic modelling: history and perspectives.J Pharmacokinet Pharmacodyn. 2006 Jun;33(3):227-79. doi: 10.1007/s10928-005-9002-0. Epub 2006 Jan 11. J Pharmacokinet Pharmacodyn. 2006. PMID: 16404503 Review.
-
Use of in vitro-in vivo correlation to predict the pharmacokinetics of several products containing a BCS class 1 drug in extended release matrices.Pharm Res. 2013 Jan;30(1):179-90. doi: 10.1007/s11095-012-0861-y. Epub 2012 Aug 22. Pharm Res. 2013. PMID: 22910891
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources